Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases
Journal of Neurology, Neurosurgery and Psychiatry, ISSN: 0022-3050, Vol: 42, Issue: 7, Page: 640-641
1979
- 105Citations
- 41Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations105
- Citation Indexes98
- 98
- CrossRef73
- Patent Family Citations7
- Patent Families7
- Captures41
- Readers41
- 41
- Mentions1
- News Mentions1
- News1
Most Recent News
Are 5HT7 Receptors Possible Target for Multiple Sclerosis?
Antony Justin*, Deepthi Murugan, Meghana Basavaraj, Ashwini Prem Kumar Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty 643
Article Description
Tryptophan and competing neutral amino acid levels were found to be diminished in the plasma of patients with multiple sclerosis and degenerative diseases, the greatest decrease being of tryptophan. Cerebrospinal fluid tryptophan was decreased in multiple sclerosis and motor neurone disease, while leucine and valine were increased. These changes might lead to decreased synthesis of brain serotonin and brain proteins. The ratio between neutral amino acids and tryptophan might be used as an ancillary test in the screening of degenerative diseases.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0018366299&origin=inward; http://dx.doi.org/10.1136/jnnp.42.7.640; http://www.ncbi.nlm.nih.gov/pubmed/479903; https://jnnp.bmj.com/lookup/doi/10.1136/jnnp.42.7.640; https://dx.doi.org/10.1136/jnnp.42.7.640; https://jnnp.bmj.com/content/42/7/640
BMJ
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know